ADVFN - Advanced Financial Network.
HOME» LSE » G » GSK Share Price » GSK Share News

Glaxosmithkline Share News

 Glaxosmithkline Share Price
GSK Share Price
 Glaxosmithkline Share Chart
GSK Share Chart
 Glaxosmithkline Share News
GSK Share News
 Glaxosmithkline Company Information
GSK Company Information
 Glaxosmithkline Share Trades
GSK Share Trades
 Glaxosmithkline Share Message Board
GSK Share Message Board

GlaxoSmithKline to close Crawley factory in Sussex, 493 jobs to go

LONDON (Thomson Financial) - GlaxoSmithKline PLC. has announced hundreds of people will lose their jobs when it closes its factory in Sussex in 2011, the BBC reported citing a company spokesman. Some 493 people are expected to be affected when the multinational drugs company's Crawley site closes. The company blamed the closure on "declining volumes, regulatory delays and patent expiries". A spokesman said production at the site would continue until the products had been moved to alternative facilities. The spokesperson said: "GSK sincerely regrets the potential impact of this proposal in terms of job losses and will do all it can to help staff through this difficult period. "Implementation of this proposal will be subject to consultation with trade union and staff representatives at the Crawley site. This process will begin immediately." The factory currently produces medicines to treat Parkinson's disease, heart disease, HIV/AIDS, bacterial skin infections, depression, and hypertension. tf.TFN-Europe_newsdesk@thomsonreuters.com slm COPYRIGHT Copyright Thomson Financial News Limited 2008. All rights reserved. The copying, republication or redistribution of Thomson Financial News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Financial News.

Share News for Glaxosmithkline (GSK)
DateTimeHeadline
24/07/201418:40:05FDA OK's Flonase for Sale Over the Counter in U.S.
24/07/201418:22:10FDA Oks Glaxo's Flonase Allergy Relief for Sale Over The Counter...
24/07/201411:45:12GSK Submits EMA Regulatory Application For Malaria Vaccine
23/07/201423:18:51ADR Shares End Mixed; GlaxoSmithKline Shares Trade Actively
23/07/201417:17:37LONDON MARKETS: Glaxo Slides In London After Earnings Warning
23/07/201415:16:22LONDON MARKETS: Glaxo Shares Fall In London After Earnings Warning
23/07/201412:50:33Genmab: 2Q Sales of Leukemia Drug Arzerra Totaled GBP12.8 Million
18/07/201423:53:06GlaxoSmithKline plc 2Q 2014 -- Forecast
17/07/201414:49:32GlaxoSmithKline: Melanoma Drug Study Shows Favorable Results
16/07/201412:14:25EUROPE MARKETS: European Stocks Jump After Strong U.K., Chinese...
16/07/201408:09:44GlaxoSmithKline Starts 3rd Phase Study Of Pulmonary Disease Treatment...
15/07/201421:49:26U.S. Hot Stocks: Hot Stocks to Watch
14/07/201423:39:18Codexis Shares Surge on GlaxoSmithKline Licensing Pact -- Update
14/07/201423:37:01Codexis in License Pact With GlaxoSmithKline
04/07/201413:07:17EU Approves Glaxo's Mekinist as Melanoma Treatment
03/07/201419:00:19ADR Shares End Higher; NQ Mobile Shares Trade Actively
03/07/201415:52:00EU Approves GlaxoSmithKline and Genmab's Leukemia Treatment
30/06/201422:04:08ADR Shares End Mixed; Philips, America Movil Trade Actively
30/06/201413:58:36Glaxo, Theravance File Asthma Drug Application with FDA
25/06/201411:45:09Glaxo Launches Phase 3 Study Into Eltrombopag Effect on MDS Sufferers

Glaxosmithkline Plc and other London Stock Exchange share prices are delayed by at least 20 minutes.
All other share price data is delayed by at least 15 minutes unless otherwise stated. By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US noad